• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

2
2
2
2

COUNTRY

2
1

CATEGORIES

  • 44
  • 15
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

6
44
59
77

PUBLISHED

0
1
3
77

PRODUCT TYPE

71
4
2

Search "Lorus Therapeutics Incorporated" returned 77 results.

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

July 2014
FROM
Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review

Lorus Therapeutics Inc (LOR) - Financial and Strategic SWOT Analysis Review Summary Lorus Therapeutics Inc. (Lorus) is a biopharmaceutical company with focus on the discovery, research and development...

September 2012
FROM

Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma

“Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma” provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where...

February 2010
FROM

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant' provides in-depth analysis...

April 2014
FROM

Melanoma - Pipeline Review, H2 2013

Melanoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline...

September 2013
FROM

Colon Cancer - Pipeline Review, H2 2013

Colon Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM
Analysis of Genta Incorporated Analysis of Genta Incorporated - Product Thumbnail Image Special Offer Sale Banner

Analysis of Genta Incorporated

Analysis of Genta Incorporated. A complete and comprehensive analysis of Genta Incorporated, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry,...

April 2013
FROM

Colon Cancer - Pipeline Review, H1 2014

Colon Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2014’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides...

February 2014
FROM

Staphylococcus Aureus Infections - Pipeline Review, H1 2013

Staphylococcus Aureus Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Staphylococcus Aureus Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

May 2013
FROM

Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This...

May 2014
FROM
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 Gram-Positive Bacterial Infections - Pipeline Review, H1 2013 - Product Thumbnail Image

Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Gram-Positive Bacterial Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Melanoma - Pipeline Review, H2 2012 Melanoma - Pipeline Review, H2 2012 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2012

Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H2 2012', provides an overview of the Melanoma therapeutic pipeline. This report provides information...

August 2012
FROM

Ovarian Cancer - Pipeline Review, H1 2014

Ovarian Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report...

April 2014
FROM

Prostate Cancer - Pipeline Review, H2 2014

Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Prostate Cancer - Pipeline Review, H1 2014

Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This...

June 2014
FROM
Melanoma - Pipeline Review, H1 2013 Melanoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2013

Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Intestinal Cancer - Pipeline Review, H2 2012 Intestinal Cancer - Pipeline Review, H2 2012 - Product Thumbnail Image

Intestinal Cancer - Pipeline Review, H2 2012

Intestinal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Intestinal Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report...

December 2012
FROM
Metastatic Melanoma - Pipeline Review, H2 2012 Metastatic Melanoma - Pipeline Review, H2 2012 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H2 2012

Metastatic Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Metastatic Melanoma - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This...

September 2012
FROM
Colon Cancer - Pipeline Review, H1 2013 Colon Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2013

Colon Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.